KCKeya Chaudhuri

Keya Chaudhuri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Keya Chaudhuri has a total of 104 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • COL1A2 Polymorphism contributes to Oral submucous fibrosis: A possible role in inducing alternative splicing in areca chewers

    by Atul Katarkar, Ushapati Roy, Sanjit Mukherjee, Jay G. Ray, Keya Chaudhuri

    Oral submucous fibrosis (OSMF) is a chronic inflammatory disease of the oral cavity but the pathogenesis of the disease is still uncertain among the areca nut chewers. Every chewer does not show up with fibrotic changes that further extend to genetic basis of OSMF pathogenesis. Genetic predisposition has been now identified as a major risk factor for increasing the susceptibility toward the disease among these chewers. In this study, two single nucleotide polymorphism (SNP) of COL1A2 rs42542 (Exon 28, G1645C) and rs421587 (Intron 28, 665+15A>G) showing mRNA splice variant trait with exon 28 skipping, extended exon 28 and intron 28 retention. The polymorphisms of the COL1A2 gene was identified by polymerase chain reaction‐direct genomic DNA sequencing from 187 patients with OSMF and 188 control participants matched on age, gender, and ethnicity. COL1A2 alternative splice variants from mRNA in human oral biopsy tissues obtained from OSMF patient and controls were confirmed by using reverse transcription PCRs (RT‐PCRs). Significant genotypic associations were observed for an exon 28 SNP (GC; P < [OR‐2.35; CI {1.44‐3.83}; P < .001] and CC [OR‐6.99; CI {1.83‐31.24}; P = .001) induces Ala to Pro substitution at amino acid 459 of COL1A2 in OSMF patients. Exon skipping is significantly associated with both the SNPs. Our results confirm the role of rs42542 and rs421587 in COL1A2 alternative splicing and support a strong role in susceptibility to OSMF, and could have served as surrogate markers.


  • Oral submucous fibrosis: A global challenge. Rising incidence, risk factors, management, and research priorities

    by Jay Gopal Ray, Raghunath Chatterjee, Keya Chaudhuri

    Oral submucous fibrosis is a potentially malignant disorder of the oral cavity, with a high rate of malignant transformation. It is very common among habitual areca nut chewers. The pathogenesis of oral submucous fibrosis is not well established, but it is believed to be a disease of multifactorial origin, including areca nut chewing, ingestion of chilies, genetic factors, immunologic processes and nutritional deficiencies. Genetically susceptible individuals when exposed to areca nut chewing develop this disease over a variable period of time. Oral submucous fibrosis is considered to be a disease of collagen metabolism. Several genetic factors are reported but there is no consensus about the exact mechanism of disease initiation. Variations in histopathological presentation are noted among oral submucous fibrosis patients with habitual areca nut chewing in different forms and other additive agents, eg betel quid, pan masala and gutkha, together with a variety of tobacco habits. The role of epigenetic modifications, such as miRNAregulation, andDNAmethylation is also being reported as part of the pathogenesis of oral submucous fibrosis. A combined approach, including analysis of genetic and epigenetic regulations with different habits, might be helpful to better understand the contributory factors and pathogenesis of this serious disorder.


  • Solvent‐Dependent Nanostructures Based on Active π‐Aggregation Induced Emission Enhancement of New Carbazole Derivatives of Triphenylacrylonitrile

    by Santu Maity, Krishnendu Aich, Chandraday Prodhan, Keya Chaudhuri, Ajoy Kumar Pramanik, Siddhartha Das, Jhuma Ganguly

    In the present study, the carbazole and 2,3,3‐triphenylacrylonitrile (TPAN) nanostructures (2‐CTPAN and 2,2′‐CTPAN) have been designed and synthesized by Pd‐catalyzed Sonogashira cross‐coupling reaction. CTPAN exhibit aggregation‐induced emission enhancement (AIEE) behavior in water with high fluorescence quantum yield. Both the compounds show tunable self‐assembly in water as well as in N,N‐dimethylformamide (DMF) by extended π–π stacking interactions. CTPAN can be self‐assembled into spherical particles in water and the structures of these self‐assemblies have been investigated using X‐ray diffraction. Interestingly, 2‐CTPAN and 2,2′‐CTPAN form organogels with a critical gelation concentration (CGC) of 11 and 15 mg mL−1, respectively, in DMF and exhibit acicular and rod shaped morphology, respectively. The single‐crystal structure of 2‐CTPAN shows that the intermolecular C−H⋅⋅⋅π interactions lock the molecular conformation into a staircase‐shaped supramolecular assembly. These AIEE active compounds reveal high water dispersibility, strong yellow fluorescence with high quantum yield, promising photostability and excellent biocompatibility, which make them potential bioimaging agents.


  • Open Access

    Evaluation of Efficacy of Curcumin along with Lycopene and Piperine in the Management of Oral Submucous Fibrosis

    by Basudev Mahato, Chandraday Prodhan, Samir Mandal, Avirup Dutta, Parna Kumar, Tushar Deb, Tarun Jha, Keya Chaudhuri

    Context: Oral submucous fibrosis (OSMF) is a high-risk premalignant condition of the oral cavity and oropharynx. Complete regression of the disease is still not possible with available treatment modalities. Aims: The aim of the study was to evaluate the efficacy of curcumin, lycopene, and piperine as a combination in the management of OSMF. Settings and Design: Efficacy was evaluated on the basis of improvement in clinical parameters (i.e., visual Analog Scale [VAS]) score for burning sensation, mouth opening (MO), mucosal flexibility (MF), and tongue protrusion [TP]). Materials and Methods: Forty patients clinically and histopathologically diagnosed with OSMF were included in the study; patients were administered with the above-stated drug combination, and clinical parameters were evaluated at regular intervals to compare the pre- and post-treatment measurements. Statistical Analysis Used: Paired t-test was done to evaluate significance of the results. Results: Highly significant improvement was observed for posttreatment reduction in VAS score for burning sensation and increase in MO (P < 0.001). Significant improvement was also observed in the increase of MF and TP. Posttreatment histopathological evaluation also revealed reepithelialization, indicated by significant increase in the epithelial thickness as found through quantitative image analysis. Immunohistochemical studies with Col1A1 showed decrease in collagen deposition. Conclusions: Taken together, the present study proposes the usage of combination drug therapy for the management of OSMF as an effective and affordable way.


  • Identification of over expressed proteins in oral submucous fibrosis by proteomic analysis

    by Tapasi Das, Chandraday Prodhan, Santanu Patsa, Jay Gopal Ray, Keya Chaudhuri

    Early detection and identification of oral pre‐malignancy or malignancy help in management of the disease and improve survival rates. Oral submucous fibrosis (OSMF) is a major threat to public health worldwide and especially in Southeast Asian countries. Identification of biomarkers is a necessary step toward early diagnosis and treatment. In this study, differentially expressed proteins between oral submucous fibrotic tissue and normal control tissues were recorded by proteomic analysis using two dimensional electrophoresis (2DE) and MALDI TOF mass spectrometry. By proteomic analysis, 15 proteins were found to be upregulated and 10 proteins downregulated in the OSMF tissues than the control tissues; among these identified proteins, Hsp‐70 1B, Calreticulin, and Lumican variant exhibited higher expression in OSMF tissues compared to the control tissues. Immunohistochemical analysis also showed elevated expression of these in OSMF tissues. Further validation was done by real time quantitative RT‐PCR analysis; gene expression of Hsp‐70 1B, Calreticulin, and Lumican variant were significantly increased (6.2‐, 3.3‐, 2.8‐ fold, respectively), whereas Enolase 1 was decreased by 0.5 fold in the OSMF tissues, consistent with proteomic results. The expression of proteins indicates that various cellular signaling pathways must be involved in the processes of fibrosis and suggests that expressed protein molecules play an important role in the pathogenesis of OSMF. These identified proteins may be potentially used in future studies of OSMF enabling to determine diagnostic marker or therapeutic targets of this precancerous condition of oral cavity.


  • Expedient synthesis of a phenanthro-imidazo-pyridine fused heteropolynuclear framework via CDC coupling: a new class of luminophores

    by Biswadip Banerji, Satadru Chatterjee, K. Chandrasekhar, Suvankar Bera, Leena Majumder, Chandraday Prodhan, Keya Chaudhuri

    We herein report the design and synthesis of a group of fused phenanthro-imidazo[1,2-a]pyridine derivatives as a new class of luminescent materials through a Pd(ii) catalyzed intramolecular CDC coupling.


  • Fluorescent sensing of Al 3+ by benzophenone based Schiff base chemosensor and live cell imaging applications: Impact of keto-enol tautomerism

    by Barnali Naskar, Ritwik Modak, Yeasin Sikdar, Dilip K. Maiti, Antonio Bauzá, Antonio Frontera, Atul Katarkar, Keya Chaudhuri, Sanchita Goswami